Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

What Stakeholders Think About CER: Now in a Booklet and at a Conference Near You

June 25, 2013

When you say “CER,” what are people thinking? The findings from NPC’s annual survey of health care stakeholders and their opinions of comparative effectiveness research and the environment for decision-making are now available in a new booklet (print and online as a PDF, along with an archived webinar). According to the survey results, stakeholders have growing expectations for the use of CER as a tool for improving health care decision-making. Their views also have changed from previous years in terms of which organizations were expected to play a significant role in specific aspects of CER, such as research priorities, methods and standards.

The survey’s findings further detail where stakeholders expect CER to go within the next 3-5 years, and what organizations they expect to lead each aspect of funding and conducting the research.

NPC research staff are presenting the survey results at two meetings this week. Health Research Services Director Kimberly Westrich will deliver remarks tomorrow at the Drug Information Association Annual Meeting in Boston, and Research Associate Adam Lustig presented a poster at the AcademyHealth Annual Research Meeting in Baltimore, Maryland.

Blog Post

CER Tweets of the Week (April 14-18, 2014)

This week, health care stakeholders highlighted both future and past events focused on comparative effectiveness research (CER). They tweeted about...
Blog Post

CER Tweets of the Week (April 7-11, 2014)

Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this week. They tweeted about the National...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
Blog Post

CER Tweets of the Week (March 31- April 4, 2014)

This week, health care stakeholders on Twitter highlighted the many activities and sessions at the Academy of Managed Care Pharmacy’s (AMCP) 26th...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

Eli Lilly and Company Joins the National Pharmaceutical Council

Washington, D.C. (January 22, 2014)—The National Pharmaceutical Council (NPC) today announced that Eli Lilly and Company has joined the health care...
Press Release

Boehringer Ingelheim’s Jeff Huth Elected as National Pharmaceutical Council’s Chairman of the Board

Washington, DC (November 8, 2013)--The National Pharmaceutical Council (NPC) today announced that Jeff Huth, Senior Vice President, Managed Markets,...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
YouTube Videos

Engaging Patients in Research

National Pharmaceutical Council President Dan Leonard explains why it's important to include patients throughout the research process. He says that...
YouTube Videos

Patient Input on What Makes Comparative Effectiveness Research Useful

Myrl Weinberg, chief executive officer of the National Health Council, says that many patients are still concerned about how comparative...
YouTube Videos

Developing Usability Criteria for Comparative Effectiveness Research

Avalere Health Senior Manager Sung Hee Choe outlines her work with the National Health Council to bring stakeholders together to develop the criteria...
Blog Post

CER Tweets of the Week (April 14-18, 2014)

This week, health care stakeholders highlighted both future and past events focused on comparative effectiveness research (CER). They tweeted about...
Blog Post

CER Tweets of the Week (April 7-11, 2014)

Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this week. They tweeted about the National...
Blog Post

CER Tweets of the Week (March 31- April 4, 2014)

This week, health care stakeholders on Twitter highlighted the many activities and sessions at the Academy of Managed Care Pharmacy’s (AMCP) 26th...
Blog Post

4/8 Webinar on CER Collaborative: Tools You Can Use

The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes...

Research

National Pharmaceutical Council 2013 Annual Report

The 2013 Annual Report highlights NPC's research, educational and partnership activities throughout...
  •  
  • 1 of 13
  • >

Commentary & Testimony